Institutional Ownership
Bioline Rx Limited
CUSIP 09071M304SPONSORED ADRBLRXQ1 2026
Institutional Holders
12
13F filers
Shares Held
19.5K
Aggregate institutional
Institutional Value
$45.0K
Q1 2026
Net New Holders
-2
1 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions1
Increased1
Decreased3
Sold out3
Institutional Holders
12 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Xtx Topco Ltd | 10.9K | $25.3K | +10.9K | New |
| 2 | Rhumbline Advisers | 2.4K | $5.4K | −1.0K | Reduced |
| 3 | Bnp Paribas Financial Markets | 1.8K | $4.1K | +300 | Added |
| 4 | Wells Fargo & Company/Mn | 1.8K | $4.0K | 0 | Held |
| 5 | Citigroup Inc | 1.7K | $4.0K | −310 | Reduced |
| 6 | Ubs Group AG | 529 | $1.2K | −1.4K | Reduced |
| 7 | Nemes Rush Group LLC | 250 | $575 | 0 | Held |
| 8 | Morgan Stanley | 100 | $230 | 0 | Held |
| 9 | Osaic Holdings, Inc. | 26 | $59 | 0 | Held |
| 10 | Rockefeller Capital Management L.P. | 12 | $28 | 0 | Held |
2 more institutional holders on Premium
See every fund holding Bioline Rx Limited, with full quarter-over-quarter share changes.
Unlock all holders